KDIGO Clinical Practice Guidelines for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Sv	Tables and figures
Svii	Disclaimer
Sviii	Work Group membership
Six	KDIGO Board Members
Sx	Abbreviations and acronyms
Sxi	Reference Keys
Sxii	Abstract

S1	Foreword

S3	Guideline 1:	Introduction and definition of CKD–MBD and the development of the guideline statements
S9	Guideline 2:	Methodological approach
S22	Guideline 3.1:	Diagnosis of CKD–MBD: biochemical abnormalities
S32	Guideline 3.2:	Diagnosis of CKD–MBD: bone
S44	Guideline 3.3:	Diagnosis of CKD–MBD: vascular calcification
S50	Guideline 4.1:	Treatment of CKD–MBD targeted at lowering high serum phosphorus and maintaining serum calcium
S70	Guideline 4.2:	Treatment of abnormal PTH levels in CKD–MBD
S90	Guideline 4.3:	Treatment of bone with bisphosphonates, other osteoporosismedications, and growth hormone
S100	Guideline 5:	Evaluation and treatment of kidney transplant bone disease
S111	Guideline 6:	Summary and research recommendations

S87	Biographic and disclosure information
S120	Acknowledgments
S121	References